Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies

被引：137
|
作者：
Shah, Nirav N. [1 ]
Maatman, Theresa [2 ]
Hari, Parameswaran [1 ]
Johnson, Bryon [1 ]
机构：
[1] Med Coll Wisconsin, Div Hematol & Oncol, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
来源：
FRONTIERS IN ONCOLOGY | 2019年 / 9卷
关键词：
CAR-T; antigen escape; B-cell NHL; B-cell ALL; immunotherapy; ANTIGEN ESCAPE; RECEPTOR; EFFICACY; RESISTANCE; LEUKEMIA;
D O I：
10.3389/fonc.2019.00146
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chimeric antigen receptor (CAR) modified T cell therapy has revolutionized the treatment of relapsed and refractory hematological malignancies. Through targeting of the CD19 antigen on B cells durable remissions have been achieved in patients with B cell non-Hodgkin lymphoma and acute lymphoblastic lymphoma. Despite impressive responses, multiple escape mechanisms to evade CAR-T cell therapy have been identified, among which the most common is loss of the target antigen. In this review we will highlight outcomes to date with CD19 CAR-T cell therapy, describe the current limitations of single targeted CAR-T therapies, review identified tumor escape mechanisms, and lastly discuss novel strategies to overcome resistance via multi-targeted CAR-T cells.
引用
收藏
页数：7
相关论文
共 50 条
  • [11] Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
    Rodgers, David T.
    Mazagova, Magdalena
    Hampton, Eric N.
    Cao, Yu
    Ramadoss, Nitya S.
    Hardy, Ian R.
    Schulman, Andrew
    Du, Juanjuan
    Wang, Feng
    Singer, Oded
    Ma, Jennifer
    Nunez, Vanessa
    Shen, Jiayin
    Woods, Ashley K.
    Wright, Timothy M.
    Schultz, Peter G.
    Kim, Chan Hyuk
    Young, Travis S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (04) : E459 - E468
  • [12] CAR-T Cell Therapy for T-Cell Malignancies
    Testa, Ugo
    Chiusolo, Patrizia
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [13] Tumor microenvironment and CAR-T cell immunotherapy in B-cell lymphoma
    Cai, Fengqing
    Zhang, Junfeng
    Gao, Hui
    Shen, Hongqiang
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 223 - 235
  • [14] Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignancies
    Manni, Simona
    Del Bufalo, Francesca
    Merli, Pietro
    Silvestris, Domenico Alessandro
    Guercio, Marika
    Caruso, Simona
    Reddel, Sofia
    Iaffaldano, Laura
    Pezzella, Michele
    Di Cecca, Stefano
    Sinibaldi, Matilde
    Ottaviani, Alessio
    Quadraccia, Maria Cecilia
    Aurigemma, Mariasole
    Sarcinelli, Andrea
    Ciccone, Roselia
    Abbaszadeh, Zeinab
    Ceccarelli, Manuela
    De Vito, Rita
    Lodi, Maria Chiara
    Cefalo, Maria Giuseppina
    Mastronuzzi, Angela
    De Angelis, Biagio
    Locatelli, Franco
    Quintarelli, Concetta
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [15] Updates on CAR T-cell therapy in B-cell malignancies
    Jacoby, Elad
    Shahani, Shilpa A.
    Shah, Nirali N.
    IMMUNOLOGICAL REVIEWS, 2019, 290 (01) : 39 - 59
  • [16] T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategies
    Maurer, Katie
    Jacobson, Caron A.
    LEUKEMIA & LYMPHOMA, 2025,
  • [17] Bispecific CAR T-cells for B-cell Malignancies
    Furqan, Fateeha
    Shah, Nirav N.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (08) : 1005 - 1015
  • [18] Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies
    Garcia-Calderon, Clara Beatriz
    Sierro-Martinez, Belen
    Garcia-Guerrero, Estefania
    Sanoja-Flores, Luzalba
    Munoz-Garcia, Raquel
    Ruiz-Maldonado, Victoria
    Jimenez-Leon, Maria Reyes
    Delgado-Serrano, Javier
    Molinos-Quintana, Agueda
    Guijarro-Albaladejo, Beatriz
    Carrasco-Brocal, Inmaculada
    Lucena, Jose-Manuel
    Garcia-Lozano, Jose-Raul
    Blazquez-Goni, Cristina
    Reguera-Ortega, Juan Luis
    Gonzalez-Escribano, Maria-Francisca
    Reinoso-Segura, Marta
    Briones, Javier
    Perez-Simon, Jose Antonio
    Caballero-Velazquez, Teresa
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [19] Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies
    Wang, Na
    Hu, Xuelian
    Cao, Wenyue
    Li, Chunrui
    Xiao, Yi
    Cao, Yang
    Gu, Chaojiang
    Zhang, Shangkun
    Chen, Liting
    Cheng, Jiali
    Wang, Gaoxiang
    Zhou, Xiaoxi
    Zheng, Miao
    Mao, Xia
    Jiang, Lijun
    Wang, Di
    Wang, Qiuxiang
    Lou, Yaoyao
    Cai, Haodong
    Yan, Dandan
    Zhang, Yicheng
    Zhang, Tongcun
    Zhou, Jianfeng
    Huang, Liang
    BLOOD, 2020, 135 (01) : 17 - 27
  • [20] Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies
    Huang, Yuxian
    Qin, Yinjie
    He, Yingzhi
    Qiu, Dezhi
    Zheng, Yeqin
    Wei, Jiayue
    Zhang, Lenghe
    Yang, Dong-Hua
    Li, Yuhua
    DRUG RESISTANCE UPDATES, 2024, 74
12345